Tumor‐associated macrophages (TAMs)‐derived CCL18 activates the FAK or Pyk2/Src signaling to mediate the epithelial‐mesenchymal transition and invasion of breast cancer cells.29, 46, 47. Here, CCL18 is linked to breast cancer.